Philadelphia, PA, 12 October, 2010 Elsevier, a world-leading publisher of scientific, technical and medical information products and services, is pleased to announce that as of January 2011 Elsevier will publish The Journal of Molecular Diagnostics (JMD) in partnership with the Association for Molecular Pathology (AMP) and the American Society for Investigative Pathology (ASIP).
The Journal of Molecular Diagnostics, the official publication of the Association for Molecular Pathology and co-owned by the American Society for Investigative Pathology, publishes high-quality original papers on scientific advances in the translation and validation of molecular discoveries in medicine into the clinical diagnostic setting, and the description and application of technological advances in the field of molecular diagnostic medicine. Articles include studies in oncology, infectious disease, inherited disease or predisposition to disease, as well as technical advances in molecular diagnosis, and application of diagnostic methodologies in clinical trials. Editor-in-Chief, Timothy J. O’Leary (Washington, DC), along with the JMD’s Associate Editors, Editorial Board, and contributing authors represent many of the recognized authorities in the field.
“Elsevier is thrilled to partner with AMP and ASIP to publish the JMD. The journal is at the forefront in publishing translational research and technological advances in molecular medicine. We welcome the journal and the societies into the Elsevier family,” states Andrew Berin, Publishing Director, Elsevier.
Dr. Mark E. Sobel, Executive Officer of both the Association for Molecular Pathology and the American Society for Investigative Pathology, states, “AMP and ASIP are confident that partnering with Elsevier will enable us to further our goal of globally promoting clinical applications and research in molecular pathology by expanding the reach and impact of the high-quality articles published in The Journal of Molecular Diagnostics.”